Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSemaglutide does not directly cancel out hormonal contraceptives, but there is a practical wrinkle worth knowing before you start. Because semaglutide slows how quickly the stomach empties, oral contraceptive pills may be absorbed more slowly or less completely in some people — a consideration that affects whether your pill provides full protection. The short version: if you take the oral contraceptive pill and are starting semaglutide, talk to your prescriber before your first injection. These are prescription-only medicines, and a clinician will look at your full picture (including the contraceptives you use) before approving treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The claim that semaglutide makes the contraceptive pill completely ineffective is an overstatement, and a common one. What the science actually shows is more nuanced. Semaglutide, like other GLP-1 receptor agonists, delays gastric emptying: food and oral medicines pass through the stomach more slowly. In theory, this could alter the rate at which an oral contraceptive is absorbed. A slower absorption rate does not automatically mean a lower total dose reaches your bloodstream, but it can shift the timing and peak concentration of the drug.
The NHS medicines information for semaglutide reflects this nuance carefully. It does not state that semaglutide nullifies oral contraception. It does flag the interaction as something to discuss with your prescriber, particularly if you rely on a pill with a narrow absorption window. That is a meaningful distinction, and a good reason not to take advice from social media posts that flatten a pharmacokinetic question into a yes or no.
If you use an oral contraceptive and are considering Wegovy, our page on whether you can take Wegovy on birth control explains what to raise during your consultation and why prescribers field this question regularly.
NHS guidance (including the NHS England weight-management injections resource) draws a clear line between semaglutide and tirzepatide on this point. For semaglutide, there is currently no confirmed clinical evidence that it reduces oral contraceptive effectiveness in practice. The interaction is theoretical, based on the gastric-emptying mechanism, rather than trial data showing contraceptive failures.
Tirzepatide sits differently. Because it activates two receptors (GIP and GLP-1) and tends to produce more pronounced gastric-emptying effects, the MHRA advises women on oral contraceptives to add a non-oral method (condoms, for instance) for the first four weeks of tirzepatide treatment and for four weeks after every dose increase. If you want to understand the full picture for semaglutide specifically, our page on whether Wegovy messes with birth control walks through how that guidance compares, and you can also read more about how it applies to Mounjaro on our page about whether Wegovy affects birth control differently to tirzepatide.
The practical upshot for semaglutide users: the precaution is not mandatory in the same way, but it is a conversation worth having, especially if you start a new pack of pills around the same time as starting injections.
Gastric emptying only matters for medicines that pass through the stomach. Non-oral hormonal contraceptives bypass this entirely. The contraceptive patch, hormonal implant, hormonal IUD (coil), contraceptive injection, and vaginal ring all deliver hormones directly through skin, tissue or mucous membrane, semaglutide's effect on your digestive system is irrelevant to how they work.
Barrier methods are similarly unaffected. If you have been thinking about switching from the pill for other reasons, starting GLP-1 treatment can be a natural prompt to revisit that conversation with your GP or sexual health clinic. None of this is urgent action territory for most people on semaglutide, but it is a good-faith discussion to have rather than a question to leave unresolved.
If you are exploring weight-loss treatments and want to understand how a prescriber would approach your contraception question specifically, that assessment happens as part of the consultation, it is not an afterthought. Some people also ask whether supplements interact with treatment; our page on ashwagandha and Wegovy covers how that kind of question is handled too.
This sits adjacent to the contraception question and is worth addressing clearly. Semaglutide is not recommended during pregnancy, while breastfeeding, or when actively trying to conceive. That is the position set out in the prescribing information, and it applies regardless of the reason you are taking it. If you are planning a pregnancy, your prescriber will discuss stopping treatment in advance.
The contraception conversation during a GLP-1 consultation is therefore dual-purpose: checking for interactions with your current method, and confirming that appropriate contraception is in place for the duration of treatment. A prescriber reviewing your case at nume will cover both. These are not tick-box questions; they are the kind of clinical detail that an independent prescriber is required to work through before issuing a prescription. Check your eligibility and start a free consultation to have those questions answered properly.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.